Clinical characteristics of exacerbations in parkinson disease

Neurologist

Volumn 18, Issue 3, 2012, Pages 120-124

  Zheng, Karen S ^a   Dorfman, Benjamin J ^a   Christos, Paul J ^a   Khadem, Nasim R ^a   Henchcliffe, Claire ^a   Piboolnurak, Panida ^a   Nirenberg, Melissa J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

disability; exacerbation; health care utilization; Parkinson disease; quality of care

Indexed keywords

LEVODOPA;

ADULT; AGED; ANXIETY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; FEMALE; HUMANS; LEVODOPA; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MOVEMENT; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS; PARKINSON DISEASE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84861118765     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e318251e6f2     Document Type: Article

References (19)

1. Nutt JG, Wooten GF. Clinical practice. Diagnosis and initial management of Parkinson's disease. N Engl J Med. 2005;353: 1021-1027. (Pubitemid 41262336)
2. Ahlskog JE. Initial symptomatic treatment of Parkinson's disease. In: Adler CH, Ahlskog JE, eds. Parkinson's Disease and Movement Disorders: Diagnosis and Treatment Guidelines for the Practicing Physician. Jacksonville: Humana Press; 2000:115-128.
3. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5:235-245. (Pubitemid 43238347)
4. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368-376. (Pubitemid 351441488)
5. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525-535. (Pubitemid 44262284)
6. Nirenberg MJ, Fahn S. The role of levodopa and catechol-O- methyltransferase inhibitors. In: Schapira AH, Olanow CW, eds. Principles of Treatment in Parkinson's Disease. Philadelphia: Butterworth Heinemann Elsevier; 2005:3-24.
7. Nirenberg MJ. PD ExpertBriefing: Parkinson's disease and its treatment: secrets, myths, and misconceptions, 2009. Available at http://www.pdf.org/ parkinson-briefing-treatments-myths.
8. Nirenberg MJ. Parkinson's disease secrets, myths, and misconceptions. Parkinson's Disease News & Review. Winter: Parkinson's Disease Foundation; 2009, Available at http://www.pdf.org/pdf/NL-Winter-10.pdf.
9. Granger ME. Exacerbations in parkinsonism. Neurology. 1961;11: 538-545.
10. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol. 2010;67:58-63.
11. Liu AA, Boxhorn CE, Klufas MA, et al. Clinical predictors of frequent patient telephone calls in Parkinson's disease. Parkinson-ism Relat Disord. 2011;17:95-99.
12. Khadem NR, Nirenberg MJ. Carbidopa/levodopa pharmacy errors in Parkinson's disease. Mov Disord. 2010;25:2867-2871.
13. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55: 181-184.
14. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010;67:996-1001.
15. Holt RJ, Sklar AR, Darkow T, et al. Prevalence of Parkinson's disease-induced psychosis in a large US managed care population. J Neuropsychiatry Clin Neurosci. 2010;22:105-110.
16. Fénelon G, Alves G. Epidemiology of psychosis in Parkinson's disease. J Neurol Sci. 2010;289:12-17.
17. Allan LM, Ballard CG, Allen J, et al. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry. 2007;78:671-677. (Pubitemid 46998833)
18. Allcock LM, Kenny RA, Mosimann UP, et al. Orthostatic hypotension in Parkinson's disease: association with cognitive decline? Int J Geriatr Psychiatry. 2006;21:778-783. (Pubitemid 44322851)
19. Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. What predicts mortality in Parkinson disease?: a prospective population-based long-term study. Neurology. 2010;75:1270-1276.